Linch, S., Kasiewicz, M. J., McNamara, M., Hilgart-Martiszus, I., Farhad, M., & Redmond, W. (2015). Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice. J Immunother Cancer.
Citación estilo ChicagoLinch, Stefanie, Melissa J. Kasiewicz, Michael McNamara, Ian Hilgart-Martiszus, Mohammad Farhad, and William Redmond. "Combination OX40 Agonism/CTLA-4 Blockade With HER2 Vaccination Reverses T Cell Anergy and Promotes Survival in Tumor-bearing Mice." J Immunother Cancer 2015.
Cita MLALinch, Stefanie, et al. "Combination OX40 Agonism/CTLA-4 Blockade With HER2 Vaccination Reverses T Cell Anergy and Promotes Survival in Tumor-bearing Mice." J Immunother Cancer 2015.